Global Aquaculture Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 210 pages | ID: G5E1BB75780EN
Precision Business Insights (PBI)

Abstracts

Global Aquaculture Vaccines Market

Aquaculture is defined as the rearing, breeding, and harvesting of aquatic organisms such as animals and plants present in the rivers, lakes, ponds, and oceans, major marine species are fish, plants, and shellfish. The major challenge in the fish production process is the development and presence of various diseases which can be prevented by using different types of vaccines. Vaccination to the fishes may help to reduce the use of antibiotics, which lead to increase in the fish production. Different types of vaccines available in the aquaculture vaccines market for the treatment of various diseases caused by bacterial, fungal, and viral infections.

Global aquaculture vaccines market is growing at a significant CAGR due to increase in the aquaculture farming. Increase in the water pollution, rise in the funding from government for the aquaculture development, an increase in the research and development activities regarding aquaculture vaccines by various research institutes are anticipated fuel the aquaculture vaccines market over the forecast period. Moreover, increase in the prevalence of various bacterial and viral infections in the fishes, rise in the awareness regarding vaccination, and innovation of new vaccines for the prevention of various aquatic diseases expected to bolster the aquaculture vaccines market across the globe. However, stringent regulatory policies for the vaccines approval, complexity for the storage of vaccines, a high cost of the vaccines, local allergic reactions associated with the vaccines, and less information available regarding the vaccines usage might hamper the growth of Global aquaculture vaccines market over the forecast period.

Global Aquaculture vaccines market is segmented on the basis of vaccine type, application, species type, and route of administration

Based on the vaccine type, aquaculture vaccines market is segmented into the following:

• Inactivated vaccines
• Inactivated virus or bacterial antigens
• Sub-unit vaccines
• Recombinant vaccines
• Live vaccines
• Attenuated live vaccines
• Gene-deleted live vaccines
• DNA vaccines

Based on the application, aquaculture vaccines market is segmented into the following:

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections

Based on the species type, aquaculture vaccines market is segmented into the following:

• Carp
• Salmon
• Seabass
• Sturgeon
• Trout
• Turbot
• Sea bream
• Others

Based on the route of administration, aquaculture vaccines market is segmented into the following:

• Immersion vaccination
• Injection vaccination
• Oral vaccination
• Spray vaccination

Global aquaculture vaccines market is in developing stage, several local and international players are actively involved in the development of aquaculture vaccines to increase their share in the aquaculture vaccines market. Increase in the aquatic farming expected to fuel the aquaculture vaccines market. According to FAO, in 2011, approximately 83.7 Mn tonnes of aquatic products were produced. Acquisitions & mergers, collaborations, launching new products, an increase in the research and development activities are some key strategies adopted by various companies in the aquaculture vaccines market. For instance, in 2015, Zoetis Inc. acquired PharmaQ for the development of aquaculture vaccines to increase company’s share in global aquaculture vaccines market. Similarly, in April 2008, 7 India and 5 Norway institutions were collaborated for the development of aquaculture vaccines to treat various viral infections. In addition, in February 2014, Benchmark Holdings strengthened the product portfolio by acquiring the assets of Zoetis aquaculture vaccines. Various pipeline products under the clinical trials expected to fuel the aquaculture vaccines market over the forecast period.

Geographically Aquaculture vaccines market is segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Europe holds the dominant share in global aquaculture vaccines market, which is attributed to the highest salmon production (according to FAO, over 1 Mn tonnes were produced in 2015) in the Norway. Increase in the awareness regarding aquaculture vaccination, a rise in the prevalence of infectious diseases, an increase in the aquaculture production in other Europe countries such as Ireland and U.K expected to fuel the aquaculture vaccines market over the forecast period. Asia Pacific is a key region for global aquaculture vaccines market owing to increase in the production of aquatic products in China, Vietnam, Bangladesh, India, and Thailand and growing research and development activities for aquaculture vaccines in Asia Pacific region also bolster the Global aquaculture vaccines market over the forecast period.

Some of the players in the global aquaculture vaccines market are zoetis (Pfizer Inc.) (U.S.), Benchmark Holdings Plc. (U.K.), Ridgeway Biologicals Ltd. (U.K.), Virbac (France), Vaccibody AS (Bio-Medisinsk Innovasjon AS) (Norway), Merck & Co. Inc. (U.S.), and Bayer Animal Health (Germany) to name a few.

In January 2017, Ridgeway Biologicals was integrated with IDT Biologika for the development of various vaccines including aquaculture

In May 2015, Vaccibody AS aquaculture research collaboration has received NOK 10 Mn from the Norwegian research council for the development of new targeting vaccines for sustainable aquaculture

Report Outline:

• The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments, and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL AQUACULTURE PHARMACEUTICALS MARKET INTRODUCTION

2.1. Global Aquaculture Vaccines Market – Taxonomy
2.2. Global Aquaculture Vaccines Market –Definitions
  2.2.1. Type of Vaccine
  2.2.2. Application
  2.2.3. Species
  2.2.4. Route of Administration

3. GLOBAL AQUACULTURE VACCINES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Aquaculture Vaccines Market Dynamics – Factors Impact Analysis
3.6. Global Aquaculture Vaccines Market – Regulations
  3.6.1. U.S
  3.6.2. Europe
  3.6.3. Japan
  3.6.4. China
3.7. Global Aquaculture Vaccines Market – Product Innovations

4. GLOBAL AQUACULTURE VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL AQUACULTURE VACCINES MARKET, BY PRODUCT, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Inactivated vaccines
  5.1.1. Inactivated virus or bacterial antigens
  5.1.2. Sub-unit vaccines
  5.1.3. Recombinant vaccines
5.2. Live vaccines
  5.2.1. Attenuated live vaccines
  5.2.2. Gene-deleted live vaccines
5.3. DNA vaccine
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.3.3. Market Opportunity Analysis

6. GLOBAL AQUACULTURE VACCINES MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Bacterial infections
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.1.3. Market Opportunity Analysis
6.2. Viral infections
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.2.3. Market Opportunity Analysis
6.3. Fungal infections
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.3.3. Market Opportunity Analysis
6.4. Parasitic infections
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.4.3. Market Opportunity Analysis

7. GLOBAL AQUACULTURE VACCINES MARKET FORECAST, BY SPECIES, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Carps
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.1.3. Market Opportunity Analysis
7.2. Carp
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.2.3. Market Opportunity Analysis
7.3. Salmon
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.3.3. Market Opportunity Analysis
7.4. Sea Bass
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.4.3. Market Opportunity Analysis
7.5. Sturgeon
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.5.3. Market Opportunity Analysis
7.6. Trout
  7.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.6.3. Market Opportunity Analysis
7.7. Turbot
  7.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.7.3. Market Opportunity Analysis
7.8. Sea bream
  7.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.8.3. Market Opportunity Analysis
7.9. Others
  7.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.9.3. Market Opportunity Analysis

8. GLOBAL AQUACULTURE VACCINES MARKET FORECAST, BY ROUTE OF ADMINISTRATION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Immersion vaccination
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.1.3. Market Opportunity Analysis
8.2. Injection vaccination
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.2.3. Market Opportunity Analysis
8.3. Oral vaccination
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.3.3. Market Opportunity Analysis
8.4. Spray vaccination
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.4.3. Market Opportunity Analysis

9. GLOBAL AQUACULTURE VACCINES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.5.3. Market Opportunity Analysis
9.6. Global Aquaculture Vaccines Market - Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Region, 2017 – 2023

10. NORTH AMERICA AQUACULTURE VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Vaccine Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Inactivated vaccines
    10.1.1.1. Inactivated virus or bacterial antigens
    10.1.1.2. Sub-unit vaccines
    10.1.1.3. Recombinant vaccines
  10.1.2. Live vaccines
    10.1.2.1. Attenuated live vaccines
    10.1.2.2. Gene-deleted live vaccines
    10.1.2.3. DNA vaccines
  10.1.3. Others
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.2.1. Bacterial infections
  10.2.2. Viral infections
  10.2.3. Fungal infections
  10.2.4. Parasitic infections
10.3. Species Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Carp
  10.3.2. Salmon
  10.3.3. Seabass
  10.3.4. Sturgeon
  10.3.5. Trout
  10.3.6. Turbot
  10.3.7. Sea bream
  10.3.8. Others
10.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.4.1. U.S.
  10.4.2. Canada
10.5. North America Aquaculture Vaccines Market - Opportunity Analysis Index, By vaccine Type, Application, Species, Route of Administration and Country, 2017 – 2023
10.6. North America Aquaculture Vaccines Market Dynamics – Trends

11. EUROPE AQUACULTURE VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Vaccine Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Inactivated vaccines
    11.1.1.1. Inactivated virus or bacterial antigens
    11.1.1.2. Sub-unit vaccines
    11.1.1.3. Recombinant vaccines
  11.1.2. Live vaccines
    11.1.2.1. Attenuated live vaccines
    11.1.2.2. Gene-deleted live vaccines
    11.1.2.3. DNA vaccines
  11.1.3. Others
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.2.1. Bacterial infections
  11.2.2. Viral infections
  11.2.3. Fungal infections
  11.2.4. Parasitic infections
11.3. Species Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Carp
  11.3.2. Salmon
  11.3.3. Seabass
  11.3.4. Sturgeon
  11.3.5. Trout
  11.3.6. Turbot
  11.3.7. Sea bream
  11.3.8. Others
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.4.1. Germany
  11.4.2. UK
  11.4.3. France
  11.4.4. Spain
  11.4.5. Italy
  11.4.6. Russia
  11.4.7. Poland
  11.4.8. Rest of Europe
11.5. Europe Aquaculture Vaccines Market - Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Country, 2017 – 2023
11.6. Europe Aquaculture Vaccines Market Dynamics – Trends

12. ASIA-PACIFIC AQUACULTURE VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Vaccine Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Inactivated vaccines
    12.1.1.1. Inactivated virus or bacterial antigens
    12.1.1.2. Sub-unit vaccines
    12.1.1.3. Recombinant vaccines
  12.1.2. Live vaccines
    12.1.2.1. Attenuated live vaccines
    12.1.2.2. Gene-deleted live vaccines
    12.1.2.3. DNA vaccines
  12.1.3. Others
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.2.1. Bacterial infections
  12.2.2. Viral infections
  12.2.3. Fungal infections
  12.2.4. Parasitic infections
12.3. Species Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Carp
  12.3.2. Salmon
  12.3.3. Seabass
  12.3.4. Sturgeon
  12.3.5. Trout
  12.3.6. Turbot
  12.3.7. Sea bream
  12.3.8. Others
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  12.4.1. Japan
  12.4.2. China
  12.4.3. India
  12.4.4. ASEAN
  12.4.5. Australia & New Zealand
  12.4.6. Rest of Asia-Pacific
12.5. Asia-Pacific Aquaculture Vaccines Market - Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Country, 2017 – 2023
12.6. Europe Aquaculture Vaccines Market Dynamics – Trends

13. LATIN AMERICA AQUACULTURE VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

13.1. Vaccine Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Inactivated vaccines
    13.1.1.1. Inactivated virus or bacterial antigens
    13.1.1.2. Sub-unit vaccines
    13.1.1.3. Recombinant vaccines
  13.1.2. Live vaccines
    13.1.2.1. Attenuated live vaccines
    13.1.2.2. Gene-deleted live vaccines
    13.1.2.3. DNA vaccines
  13.1.3. Others
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.2.1. Bacterial infections
  13.2.2. Viral infections
  13.2.3. Fungal infections
  13.2.4. Parasitic infections
13.3. Species Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.3.1. Carp
  13.3.2. Salmon
  13.3.3. Seabass
  13.3.4. Sturgeon
  13.3.5. Trout
  13.3.6. Turbot
  13.3.7. Sea bream
  13.3.8. Others
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.4.1. Brazil
  13.4.2. Mexico
  13.4.3. Argentina
  13.4.4. Venezuela
  13.4.5. Rest of Latin America
13.5. Latin America Aquaculture Vaccines Market - Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Country, 2017 – 2023
13.6. Latin America Aquaculture Vaccines Market Dynamics – Trends

14. MIDDLE EAST AND AFRICA AQUACULTURE VACCINES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

14.1. Vaccine Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  14.1.1. Inactivated vaccines
    14.1.1.1. Inactivated virus or bacterial antigens
    14.1.1.2. Sub-unit vaccines
    14.1.1.3. Recombinant vaccines
  14.1.2. Live vaccines
    14.1.2.1. Attenuated live vaccines
    14.1.2.2. Gene-deleted live vaccines
    14.1.2.3. DNA vaccines
  14.1.3. Others
14.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  14.2.1. Bacterial infections
  14.2.2. Viral infections
  14.2.3. Fungal infections
  14.2.4. Parasitic infections
14.3. Species Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  14.3.1. Carp
  14.3.2. Salmon
  14.3.3. Seabass
  14.3.4. Sturgeon
  14.3.5. Trout
  14.3.6. Turbot
  14.3.7. Sea bream
  14.3.8. Others
14.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  14.4.1. Gulf Cooperation Council (GCC) Countries
  14.4.2. Israel
  14.4.3. South Africa
  14.4.4. Rest of MEA
14.5. MEA Aquaculture Vaccines Market - Opportunity Analysis Index, By Vaccine Type, Application, Species, Route of Administration and Country, 2017 – 2023
14.6. MEA Aquaculture Vaccines Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Zoetis (Pfizer Inc.) (U.S.)
  15.2.2. Benchmark Holdings Plc. (U.K.)
  15.2.3. Ridgeway Biologicals Ltd. (U.K.)
  15.2.4. Virbac (France)
  15.2.5. Vaccibody AS (Bio-Medisinsk Innovasjon AS) (Norway)
  15.2.6. Merck & Co. Inc. (U.S.)
  15.2.7. Bayer Animal Health (Germany)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS